Chemically programmable immunity
AssigneeAltermune Technologies, LLC
InventorKary B. Mullis
Life of this patent
Estimating the term…
Abstract
The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
Claims18
An immune-diverting composition comprising an immunity linker molecule comprising
- a first binding site that when administered to an individual is capable of binding to an antibody produced from a pre-existing immunity within the individual specific for a first compound or molecule, and
- a second binding site comprising a nucleic acid aptamer or a modified nucleic acid aptamer that is capable of binding to a target, wherein the first compound or molecule and the target are not the same.
Dependencies are inferred from the claim text.